軟膠囊市場－全球產業規模、佔有率、趨勢、機會和預測，按類型、應用、最終用途、地區和競爭格局分類，2020-2030年預測

2024年全球軟膠囊市場規模為80.2億美元，預計2030年將以7.86%的複合年成長率成長至126.3億美元。軟膠囊是一種特殊的口服劑型，其內部填充液體或半液體，外層包裹著柔軟的膠狀外殼，通常由動物明膠或植物性聚合物製成。市場成長的主要促進因素包括：軟膠囊製劑本身所具有的優勢，例如更高的生物利用度和更易吞嚥；膳食補充劑和營養保健品的需求不斷成長；以及慢性疾病盛行率的上升，使得有效給藥的需求日益迫切。這些優勢有助於提高患者依從性，並拓展軟膠囊在製藥、營養保健品和化妝品等領域的應用。

主要市場促進因素

主要市場挑戰

主要市場趨勢

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球軟膠囊市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 按類型（明膠基/動物基，非動物基）
  • 依用途分類（制酸劑和抗脹氣製劑、抗貧血製劑、抗發炎藥、抗生素和抗菌藥、止咳感冒製劑、保健品、維生素和膳食補充劑、懷孕用藥、其他）
  • 依最終用途分類（製藥公司、營養保健品公司、化妝品公司、合約生產組織）
  • 按地區
  • 按公司（2024 年）
• 市場地圖

第6章：北美軟膠囊市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲軟膠囊市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區軟膠囊市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲軟膠囊市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲軟膠囊市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章：市場動態

• 促進要素
• 挑戰

第12章：市場趨勢與發展

• 併購（如有）
• 產品發布（如有）
• 最新進展

第13章：全球軟膠囊市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商議價能力
• 顧客的力量
• 替代產品的威脅

第15章：競爭格局

• Fuji Capsule Co Ltd
• Sirio Pharma Co Ltd
• Captek Softgel International Inc
• Thermo Fisher Scientific Inc
• EyePoint Pharmaceuticals Inc
• Catalent Inc
• EuroCaps Ltd
• Aenova Group GmbH
• Lonza Group AG
• Soft Gel Technologies Inc.

第16章：策略建議

第17章調查會社について,免責事項

The Global Softgel Capsules Market, valued at USD 8.02 Billion in 2024, is projected to experience a CAGR of 7.86% to reach USD 12.63 Billion by 2030. Softgel capsules represent a specialized oral dosage form, comprising a liquid or semi-liquid fill enclosed within a soft, gelatinous shell typically composed of animal gelatin or plant-based polymers. The market's growth is primarily driven by several distinct factors, including the inherent benefits of softgel formulations such as improved bioavailability and ease of swallowing, increased demand for dietary supplements and nutraceuticals, and the rising prevalence of chronic diseases necessitating effective drug delivery. These attributes facilitate enhanced patient compliance and expand application across pharmaceutical, nutraceutical, and cosmetic sectors.

Key Market Drivers

The global softgel capsules market expansion is significantly propelled by the growing demand for dietary supplements and nutraceuticals, alongside rising consumer health awareness and a proactive approach to preventive healthcare. The burgeoning nutraceutical sector, which frequently utilizes softgel formulations for their effective delivery of active ingredients, remains a primary catalyst. According to the IADSA, at the start of 2023, the worldwide market for supplements was larger than USD 170 billion, underscoring the substantial base driving softgel production in this segment. This robust demand is further amplified by a global shift towards preventative health measures and increased consumer understanding of nutrition's role in well-being. This trend encourages a consistent uptake of supplements, for which softgels offer an appealing and convenient dosage form.

Key Market Challenges

A significant challenge impeding the expansion of the global softgel capsules market is the high production costs associated with specialized encapsulation machinery, stringent manufacturing controls, and the rising prices of raw materials. These economic factors directly influence the operational profitability and growth strategies of manufacturers within the sector. The substantial investment required for advanced encapsulation technologies, alongside the ongoing expenses of maintaining rigorous quality and regulatory compliance, significantly elevates overall manufacturing overheads.

Key Market Trends

The growing consumer preference for vegan and vegetarian products, coupled with increasing health and ethical considerations, is significantly driving the adoption of plant-based encapsulation materials in the softgel capsules market. This trend involves a shift from traditional animal-derived gelatin to alternatives such as pullulan, starch, and hydroxypropyl methylcellulose, which cater to a broader demographic seeking ethical and sustainable options. The move towards plant-based ingredients is evident in manufacturing capacity, with the Pharmaceutical Research and Manufacturers of America (PhRMA) reporting that Catalent alone accounted for nearly 14% of global plant-based capsule manufacturing capacity in 2023. This expansion underscores the market's response to evolving dietary preferences and clean label demands. In a notable development, IFF introduced new pectin-based technology in April 2023 to expand its vegan softgel offerings, reflecting industry innovation in sustainable solutions.

Key Market Players

• Fuji Capsule Co Ltd
• Sirio Pharma Co Ltd
• Captek Softgel International Inc
• Thermo Fisher Scientific Inc
• EyePoint Pharmaceuticals Inc
• Catalent Inc
• EuroCaps Ltd
• Aenova Group GmbH
• Lonza Group AG
• Soft Gel Technologies Inc.

Report Scope:

In this report, the Global Softgel Capsules Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Softgel Capsules Market, By Type:

• Gelatin-Based/Animal-Based
• Non-Animal-Based

Softgel Capsules Market, By Application:

• Antacid and Anti-Flatulent Preparation
• Anti-Anemic Preparations
• Anti-Inflammatory Drugs
• Antibiotic and Antibacterial Drugs
• Cough and Cold Preparations
• Health Supplement
• Vitamin and Dietary Supplement
• Pregnancy
• Others

Softgel Capsules Market, By End Use:

• Pharmaceutical Companies
• Nutraceutical Companies
• Cosmeceutical Companies
• Contract Manufacturing Organization

Softgel Capsules Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Softgel Capsules Market.

Available Customizations:

Global Softgel Capsules Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Softgel Capsules Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Gelatin-Based/Animal-Based, Non-Animal-Based)
  • 5.2.2. By Application (Antacid and Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic and Antibacterial Drugs, Cough and Cold Preparations, Health Supplement, Vitamin and Dietary Supplement, Pregnancy, Others)
  • 5.2.3. By End Use (Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies, Contract Manufacturing Organization)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Softgel Capsules Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Application
  • 6.2.3. By End Use
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Softgel Capsules Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End Use
  • 6.3.2. Canada Softgel Capsules Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End Use
  • 6.3.3. Mexico Softgel Capsules Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End Use

7. Europe Softgel Capsules Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Application
  • 7.2.3. By End Use
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Softgel Capsules Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End Use
  • 7.3.2. France Softgel Capsules Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End Use
  • 7.3.3. United Kingdom Softgel Capsules Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End Use
  • 7.3.4. Italy Softgel Capsules Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End Use
  • 7.3.5. Spain Softgel Capsules Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End Use

8. Asia Pacific Softgel Capsules Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By End Use
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Softgel Capsules Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End Use
  • 8.3.2. India Softgel Capsules Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End Use
  • 8.3.3. Japan Softgel Capsules Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End Use
  • 8.3.4. South Korea Softgel Capsules Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End Use
  • 8.3.5. Australia Softgel Capsules Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End Use

9. Middle East & Africa Softgel Capsules Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Application
  • 9.2.3. By End Use
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Softgel Capsules Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End Use
  • 9.3.2. UAE Softgel Capsules Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End Use
  • 9.3.3. South Africa Softgel Capsules Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End Use

10. South America Softgel Capsules Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Application
  • 10.2.3. By End Use
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Softgel Capsules Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End Use
  • 10.3.2. Colombia Softgel Capsules Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End Use
  • 10.3.3. Argentina Softgel Capsules Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Softgel Capsules Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Fuji Capsule Co Ltd
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Sirio Pharma Co Ltd
• 15.3. Captek Softgel International Inc
• 15.4. Thermo Fisher Scientific Inc
• 15.5. EyePoint Pharmaceuticals Inc
• 15.6. Catalent Inc
• 15.7. EuroCaps Ltd
• 15.8. Aenova Group GmbH
• 15.9. Lonza Group AG
• 15.10. Soft Gel Technologies Inc.

16. Strategic Recommendations

17. About Us & Disclaimer